|
UA41446C2
(uk)
*
|
1995-03-27 |
2001-09-17 |
Санофі - Сінтелабо |
Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
|
|
US6440445B1
(en)
*
|
1996-09-30 |
2002-08-27 |
Brigham & Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
US6306819B1
(en)
*
|
1997-10-31 |
2001-10-23 |
Massachusetts Institute Of Technology |
Method for regulating size of vascularized normal tissue
|
|
ATE489108T1
(de)
*
|
1998-10-09 |
2010-12-15 |
Vegenics Ltd |
Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
EP1547609A1
(en)
*
|
2002-09-04 |
2005-06-29 |
Proteinexpress Co., Ltd. |
Embryo implantation inhibitor
|
|
WO2004103159A2
(en)
*
|
2003-05-14 |
2004-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating endometrium
|
|
EP1648575A4
(en)
*
|
2003-07-14 |
2009-09-16 |
Fusion Sport Internat Pty Ltd |
METHOD, DEVICE AND SYSTEM FOR SPORT TRAINING AND TESTING
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
DE602004015142D1
(de)
*
|
2003-08-29 |
2008-08-28 |
Childrens Medical Center |
Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
|
|
JP2011523551A
(ja)
*
|
2008-05-15 |
2011-08-18 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
血管形成の調節の新規ターゲット
|
|
EP2140860A1
(en)
*
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
CA2731020A1
(en)
*
|
2008-07-18 |
2010-01-21 |
Zafgen, Inc. |
Use of antiangiogenic fumagillins in the treatment of obesity
|
|
US20100159506A1
(en)
*
|
2008-07-25 |
2010-06-24 |
Cellscape Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
US8642650B2
(en)
|
2008-12-04 |
2014-02-04 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
WO2013055385A2
(en)
|
2011-10-03 |
2013-04-18 |
Zafgen Corporation |
Methods of treating age related disorders
|
|
US20120004162A1
(en)
|
2008-12-04 |
2012-01-05 |
Vath James E |
Methods of Treating an Overweight or Obese Subject
|
|
MX337575B
(es)
|
2009-10-09 |
2016-03-10 |
Zafgen Corp |
Compuestos de sulfona y métodos para lafabricación y uso de éstos.
|
|
US8815309B2
(en)
|
2010-01-08 |
2014-08-26 |
Zafgen, Inc. |
Methods of treating a subject with benign prostate hyperplasia
|
|
JP5827239B2
(ja)
|
2010-01-08 |
2015-12-02 |
ザフゲン，インコーポレイテッド |
フマギロール型化合物並びにその製造方法及び使用方法
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
US20130266578A1
(en)
|
2010-04-07 |
2013-10-10 |
Thomas E. Hughes |
Methods of treating an overweight subject
|
|
CN103079567A
(zh)
|
2010-04-17 |
2013-05-01 |
拜尔健康护理有限责任公司 |
用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
|
|
CA2805874A1
(en)
|
2010-07-19 |
2012-01-26 |
Bayer Healthcare Llc |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
AU2011281037B2
(en)
|
2010-07-22 |
2014-11-27 |
Zafgen, Inc. |
Tricyclic compounds and methods of making and using same
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
AU2011336785A1
(en)
|
2010-11-29 |
2013-06-20 |
Zafgen, Inc |
Treatment of obesity using non-daily administration of 6-0-(4 - dimethylaminoethoxy) cinnamoyl fumagillol
|
|
WO2012103333A1
(en)
|
2011-01-26 |
2012-08-02 |
Zafgen Corporation |
Tetrazole compounds and methods of making and using same
|
|
KR101875988B1
(ko)
|
2011-03-08 |
2018-07-06 |
자프겐 인크. |
옥사스피로[2.5]옥탄 유도체 및 유사체
|
|
US9242997B2
(en)
|
2011-05-06 |
2016-01-26 |
Zafgen, Inc. |
Tricyclic pyrazole sulphonamide compunds and methods of making and using same
|
|
SG194812A1
(en)
|
2011-05-06 |
2013-12-30 |
Zafgen Inc |
Partially saturated tricyclic compounds and methods of making and using same
|
|
CN103748094B
(zh)
|
2011-05-06 |
2016-06-29 |
扎夫根股份有限公司 |
三环磺酰胺化合物及其制备和使用方法
|
|
BR112014017673A8
(pt)
|
2012-01-18 |
2017-07-11 |
Zafgen Inc |
Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
|
|
WO2013109735A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
WO2013169727A1
(en)
|
2012-05-07 |
2013-11-14 |
Zafgen, Inc. |
Polymorphic salt of the oxalate salt of 6 - o - ( 4 - dimethylaminoethoxy) cinnarnoyl fumagillol and methods of making and using same
|
|
EP2846792B1
(en)
|
2012-05-08 |
2018-08-15 |
Zafgen, Inc. |
Treating hypothalamic obesity with metap2 inhibitors
|
|
WO2013169860A1
(en)
|
2012-05-09 |
2013-11-14 |
Zafgen, Inc. |
Fumigillol type compounds and methods of making and using same
|
|
MX2015005733A
(es)
|
2012-11-05 |
2016-02-10 |
Zafgen Inc |
Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
|
|
KR20150079952A
(ko)
|
2012-11-05 |
2015-07-08 |
자프겐 인크. |
트리시클릭 화합물 및 그의 제조 및 사용 방법
|
|
BR112015010196A2
(pt)
|
2012-11-05 |
2017-07-11 |
Zafgen Inc |
métodos de tratar doença do fígado
|
|
US9597309B2
(en)
|
2013-03-14 |
2017-03-21 |
Zafgen, Inc. |
Methods of treating renal disease and other disorders
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|